Under pathological conditions, FSHR has been found in granulosa cell tumors (Chu et al. 2002), ovarian surface epithelial carcinomas (Wang et al. 2003; Bose 2008; Choi et al. 2004), ovarian Sertoli-Leydig cell tumors (Choong et al. 2002), prostate cancer (Ben-Josef et al. 1999; Mariani et al. 2006; Oduwole et al. 2021), endometrial cancer (Sheng et al. 2022), neuroendocrine tumors in the appendix (Starzynski et al. 2023), and normal fat tissue (Liu et al. 2015, 2017). This evidence concerns the gene FSHR and Familial prostate cancer.